Target intelligence / Profile preview

Protein kinase A – cAMP response element-binding protein pathway (PKA–CREB pathway)

Target
PKA–CREB pathway
Molecular classification
Enzyme (Protein kinase A is a serine/threonine kinase), Transcription factor (CREB), Signal transduction pathway (Protein kinase A activates CREB via phosphorylation), Other: Pathway composed of molecular interactions
01

Overview

The **Protein kinase A – CREB pathway** is a canonical signal transduction pathway in which **cyclic AMP-dependent protein kinase A (PKA)** phosphorylates the **cAMP response element-binding protein (CREB)** at Ser133, activating its transcription factor function[1][3][4][5]. Activated CREB recruits the co-activators **CBP/p300**, enabling transcription of genes involved in **cell growth, survival, differentiation, metabolism, immune regulation, and neuronal plasticity**[1][3]. Dysregulation of this pathway contributes to tumorigenesis by promoting proliferation, resisting apoptosis, and enabling immune evasion, and also plays key roles in neuronal and hematopoietic physiology[2][6][5]. Targeting the PKA–CREB–CBP interface is considered a promising but challenging therapeutic strategy, with small molecules such as KG-501 and naphthol derivatives explored experimentally[2][4]. The pathway is often measured by assessing CREB phosphorylation and activity, which serve as potential biomarkers in multiple disease contexts[4][6][5].\n\n**Note:** The request for information about "Protein kinase A – CREB pathway" does not refer to a single molecular entity, but rather a signaling axis composed of **multiple proteins** (enzyme and transcription factor), making direct mapping to the conventions for drug targets difficult. In structured databases, separate entries exist for "Protein kinase A" (PKA) and "cAMP response element-binding protein" (CREB), not the pathway as a whole.

Other names
PKA–CREB pathwaycAMP–PKA–CREB signalingcAMP response element-binding protein pathwaycAMP-dependent protein kinase–CREB pathway
02

Mechanism of action

Direct inhibition of CREB–CBP/p300 interaction, blocking transcriptional coactivator recruitment - Inhibition of CREB phosphorylation at Ser133 via PKA antagonists - Modulation of cAMP signaling upstream (Adenosine receptor antagonism) - Inhibition of CREB–DNA binding, blocking downstream gene transcription - Promoting CREB protein degradation

03

Biological functions

Signal transductionTranscriptional regulationCell proliferationCell survivalDifferentiationMetabolismHematopoiesisImmune response/immune evasionAngiogenesisDNA repairApoptosisInflammationNeuronal plasticity and memory formation
04

Disease associations

Cancer/tumor development (including leukemia, lung cancer, breast cancer, hepatocellular carcinoma, non-small cell lung cancer, melanoma)Chemotherapy resistanceNeurodegenerative disease (via neuronal survival, neuroplasticity)Cardiovascular disease (hematopoiesis, thrombosis)Inflammation (immunosuppression, immune evasion)Other: Role in schizophrenia and psychiatric disorders (CREB dysfunction)
05

Safety considerations

Off-target effects due to homology with other KIX domain transcription factors (NF-κB, Myb, p53)Modulation of global transcriptional programs can impact cell viability and differentiationImmune suppression (overactivation via A2A–PKA–CREB pathway inhibits T cell activity)Psychiatric and neurocognitive adverse effects if chronically suppressed in the CNS (CREB critical for memory and survival)
06

Interacting drugs

KG-501 (CREB–CBP interaction inhibitor)

6 more in the full profile.

07

Biomarkers

Phosphorylated CREB (pCREB, particularly Ser133 phosphorylation state)CREB protein levelsCREB target gene expression (e.g., BCL2, Gata2)Downstream CREB-dependent mRNAs or miRNAs (e.g., miRNA-34b)

Beyond the preview

Go deeper on Protein kinase A – cAMP response element-binding protein pathway (PKA–CREB pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein kinase A – cAMP response element-binding protein pathway (PKA–CREB pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call